Snapshot from Aug 12, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical breakthrough

Arc Protein Spreads Alzheimer's Tau

Analysis based on 12 articles · First reported Jun 29, 2026 · Last updated Jun 30, 2026

Sentiment
60
Attention
4
Articles
12
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The discovery of Activity-regulated cytoskeleton-associated protein's role in spreading Tau protein in Alzheimer s disease could open new avenues for drug development in the biotechnology and pharmaceutical industries. Companies like Aera Therapeutics, Inc., which licenses intellectual property related to Activity-regulated cytoskeleton-associated protein, may see increased investor interest if these findings lead to viable therapies. This could lead to significant long-term market shifts in the healthcare sector.

Biotechnology Pharmaceuticals Healthcare

Researchers, primarily from University of Utah, have discovered that the brain protein Activity-regulated cytoskeleton-associated protein plays a crucial role in the spread of toxic Tau protein, which drives Alzheimer s disease. In mouse models, Activity-regulated cytoskeleton-associated protein was found to facilitate the transfer of Tau protein from sick to healthy brain cells via extracellular vesicles. While Activity-regulated cytoskeleton-associated protein also has a protective role in early stages by helping sick cells expel excess Tau protein, blocking its ability to transfer Tau protein to healthy cells could be a new therapeutic strategy to prevent disease progression. The findings, published in Cell (journal), suggest that targeting these Tau protein-containing extracellular vesicles could prevent further damage and cognitive decline in patients with Alzheimer s disease. Jason Shepherd and Mitali Tyagi were key researchers in this study, which received funding from various organizations including the United States — National Institutes of Health and the Alzheimer s Association.

10 Jason Shepherd co-founded VNV, LLC
10 Jason Shepherd consults for Aera Therapeutics, Inc.
10 Aera Therapeutics, Inc. licenses intellectual property
oth
Activity-regulated cytoskeleton-associated protein is a brain protein that has been discovered to help spread toxic Tau protein in Alzheimer s disease, making it a potential target for new therapies.
Importance 100.0 Sentiment 50.0
oth
Tau protein is a toxic protein whose buildup and spread are central to the progression of Alzheimer s disease. The research focuses on preventing its spread.
Importance 100.0 Sentiment -70.0
per
Jason Shepherd, a professor at University of Utah, is the senior author of the study and expresses excitement about the potential to stop Alzheimer s disease progression.
Importance 90.0 Sentiment 70.0
per
Mitali Tyagi, a postdoctoral research associate at Washington University in St. Louis and first author, conducted key research on Activity-regulated cytoskeleton-associated protein's role in Tau protein spread.
Importance 90.0 Sentiment 70.0
govactor
United States — National Institute of Neurological Disorders and Stroke provided funding for the research, supporting the scientific advancements.
Importance 40.0 Sentiment 50.0
govactor
United States — National Institutes of Health provided funding for the research, supporting the scientific advancements.
Importance 40.0 Sentiment 50.0
ngo
Chan Zuckerberg Initiative provided funding for the research, supporting the scientific advancements.
Importance 30.0 Sentiment 50.0
ngo
Alzheimer s Association provided funding for the research, supporting the scientific advancements.
Importance 30.0 Sentiment 50.0
oth
McKnight Brain Disorders Award provided funding for the research, supporting the scientific advancements.
Importance 30.0 Sentiment 50.0
oth
Jon M. Huntsman Presidential Endowed Chair fund provided funding for the research, supporting the scientific advancements.
Importance 30.0 Sentiment 50.0
ngo
Max Planck Society provided funding for the research, supporting the scientific advancements.
Importance 30.0 Sentiment 50.0
priv
Aircel provided funding for the research, supporting the scientific advancements.
Importance 30.0 Sentiment 50.0
oth
Prince provided funding for the research, supporting the scientific advancements.
Importance 30.0 Sentiment 50.0
ngo
JPB Foundation provided funding for the research, supporting the scientific advancements.
Importance 30.0 Sentiment 50.0
ngo
Cure Alzheimer s Fund provided funding for the research, supporting the scientific advancements.
Importance 30.0 Sentiment 50.0
+ 4 more entities View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.